Results 191 to 200 of about 99,271 (251)

Safety and Performance of the MOZEC Sirolimus-Eluting Coronary Balloon in the Treatment of Stenotic Coronary Artery Lesions: A Real-World, Multicenter, Post-Marketing Surveillance Study. [PDF]

Cardiol Res
Premchand Jain RK, Parikh K, Sethuraman S, Sharma K, Roy S, Vithala SR, Gollamandala KR, Packirisamy G, Mantravadi SS, Roleder T.   +9 more
europepmc   +1 more source

Expanding the Role of Drug-Coated Balloons in Treating De Novo Coronary Artery Disease. [PDF]

JACC Asia
van Veelen A, Claessen BEPM.
europepmc   +1 more source

Guide Extension-Facilitated Ostial Stenting (GEST) During Primary Coronary Angioplasty in a Patient With ST-Segment Elevation Myocardial Infarction: A Case Report. [PDF]

Cureus
Besis G, Khan Z, Win NT, Soyan M, Candilio L.   +4 more
europepmc   +1 more source

The hypothetical detrimental dog-bone effect during coronary angioplasty with compliant or non-compliant balloon. An in vitro experimental study. [PDF]

Cardiol J
Derimay F, Cellier G, Gomez A, Copel R, Ohayon J, Rioufol G, Finet G.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Coronary balloon angioplasty, stents, and scaffolds

The Lancet, 2017
Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary intervention has become one of the most common medical procedures worldwide.
Robert A. Byrne, Gregg W. Stone, John A. Ormiston, Adnan Kastrati   +3 more
openaire   +3 more sources

Kissing balloon coronary angioplasty

The American Journal of Cardiology, 1984
Balloon angioplasty of stenoses involving a bifurcation of coronary arteries carries a significant risk of permanent occlusion of I of the branches. 1 Kissing balloon angioplasty was first described for aortoplasty in the Leriche syndrome. 2 In 1981, Gruentzig introduced it into coronary angioplasty.
B. Meier
openaire   +4 more sources

Efficacy of drug‐coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry)

Catheterization and cardiovascular interventions, 2020
To evaluate the efficacy and safety of additional drug‐coated balloon (DCB) angioplasty after directional coronary atherectomy (DCA) for coronary bifurcation lesions.
S. Kitani, Y. Igarashi, E. Tsuchikane, Shigeru Nakamura, Yoshitane Seino, M. Habara, Y. Takeda, K. Shimoji, Y. Yasaka, M. Kijima   +9 more
semanticscholar   +1 more source

Optical coherence tomography analysis of late lumen enlargement after paclitaxel‐coated balloon angioplasty for de‐novo coronary artery disease

Catheterization and cardiovascular interventions, 2020
Paclitaxel‐coated balloon angioplasty for de‐novo coronary artery lesions causes late lumen enlargement (LLE), however, the mechanisms and predictors of LLE have not been elucidated.
K. Sogabe, Masahiro Koide, K. Fukui, Y. Kato, Hiroki Kitajima, Satoshi Akabame, K. Zen, Takeshi Nakamura, S. Matoba   +8 more
semanticscholar   +1 more source

Surgical Standby for Coronary Balloon Angioplasty

JAMA: The Journal of the American Medical Association, 1992
To assess the predictability of need for emergency surgery after coronary balloon angioplasty.Nonrandomized intervention study.Nonprofit university hospital.Prior to balloon angioplasty, 1000 consecutive patients were assigned to either the "standby" group (189 patients [19%]) or the "no-standby" group (811 patients [81%]).
Josiane Favre, Philip Urban, Bernhard Meier, Pierre-André Dorsaz   +3 more
openaire   +3 more sources